Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
FLOWSPARKS | UNI | May 17, 2024 | 23.00 | 0.00 |
FLOWSPARKS N.V. | FLSP | May 17, 2024 | 23.00 | 0.00 |
Fluxys Belgium SA | FLUX | May 17, 2024 | 21.80 | +1.87 |
FNG N.V | FNG | May 17, 2024 | 3.50 | 0.00 |
Foot Locker | FOOTL | May 17, 2024 | 60.04 | 0.00 |
Fountain SA | FOU | May 17, 2024 | 1.20 | 0.00 |
GALAPAGOS | GLPG | May 17, 2024 | 27.50 | +0.37 |
Genk Logist Cert | GENK | May 17, 2024 | 8.01 | 0.00 |
GENKYOTEX | GKTX | May 17, 2024 | 3.21 | 0.00 |
Gimv NV | GIMB | May 17, 2024 | 45.95 | -0.11 |
Global Graphics S.A. | GLOG | May 17, 2024 | 4.90 | 0.00 |
Greenyard NV | GREEN | May 17, 2024 | 5.40 | +0.75 |
Groupe Bruxelles Lambert SA | GBLB | May 17, 2024 | 71.55 | +0.21 |
Growners SA | GROWN | May 17, 2024 | 8.00 | 0.00 |
Hamon & Cie (International) S.A. | HAMO | May 17, 2024 | 0.78 | 0.00 |
Home Invest Belgium NV | HOMI | May 17, 2024 | 17.22 | -0.23 |
Hybrid Software Group PLC | HYSG | May 17, 2024 | 3.88 | +3.19 |
Hyloris Pharmaceuticals SA | HYL | May 17, 2024 | 11.70 | 0.00 |
IBM | IBMA | May 17, 2024 | 145.00 | 0.00 |
Iep Invest NV | IEP | May 17, 2024 | 5.65 | 0.00 |
Immo Mechelen City Center NV | MCC | May 17, 2024 | 474.00 | 0.00 |
Immo Moury SCA | IMMOU | May 17, 2024 | 30.80 | 0.00 |
Immobel - Compagnie Immobiliere de Belgique | IMMO | May 17, 2024 | 28.15 | -4.25 |
Immopool | IMMOP | May 17, 2024 | 0.01 | 0.00 |
Immupharma Plc | ALIMM | May 17, 2024 | 0.09 | 0.00 |
INCLUSIO SA/NV | INCLU | May 17, 2024 | 14.20 | -1.39 |
ING GROEP N.V. | INGA | May 17, 2024 | 16.52 | +1.84 |
Intel | INCO | May 17, 2024 | 35.11 | 0.00 |
Intervest Offices & Warehouses NV | INTO | May 17, 2024 | 20.85 | 0.00 |
Ion Beam Applications SA | IBAB | May 17, 2024 | 14.48 | +0.56 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.